Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Jobling

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|September 28, 2016
Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium InfectionBruce McCollister, Cassandra V Kotter, Daniel N Frank, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2017
Erratum for McCollister et al., Whole-Genome Sequencing Identifies <i>In Vivo</i> Acquisition of a <i>bla</i><sub>CTX-M-27</sub>-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive <i>Salmonella enterica</i> Serovar Typhimurium InfectionBruce McCollister, Cassandra V Kotter, Daniel N Frank, et al.
Mbio|November 1, 2012
A single native ganglioside GM1-binding site is sufficient for cholera toxin to bind to cells and complete the intoxication pathwayMichael G Jobling, Zhijie Yang, Wendy R Kam, et al.
Molecular Microbiology|July 9, 2002
LitR, a new transcriptional activator in Vibrio fischeri, regulates luminescence and symbiotic light organ colonizationPat M Fidopiastis, Carol M Miyamoto, Michael G Jobling, et al.
Biochemistry|March 31, 2004
Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanismClaire J O'Neal, Edward I Amaya, Michael G Jobling, et al.
Biophysical Journal|December 5, 2016
Glycolipid Crosslinking Is Required for Cholera Toxin to Partition Into and Stabilize Ordered DomainsKrishnan Raghunathan, Tiffany H Wong, Daniel J Chinnapen, et al.
Advances in Experimental Medicine and Biology|October 14, 2006
Dissection of the fusion machine of SARS-coronavirusMegan W Howard, Brian Tripet, Michael G Jobling, et al.
Biochemistry|September 16, 2010
Contribution of subdomain structure to the thermal stability of the cholera toxin A1 subunitTuhina Banerjee, Abhay Pande, Michael G Jobling, et al.
Plos One|July 2, 2011
Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable markerSheryl L W Zajdowicz, Jessica Jones-Carson, Andres Vazquez-Torres, et al.
Infection and Immunity|November 24, 2004
Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilisXin Li, Jarrod L Erbe, C Virginia Lockatell, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|September 28, 2016
Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium InfectionBruce McCollister, Cassandra V Kotter, Daniel N Frank, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2017
Erratum for McCollister et al., Whole-Genome Sequencing Identifies <i>In Vivo</i> Acquisition of a <i>bla</i><sub>CTX-M-27</sub>-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive <i>Salmonella enterica</i> Serovar Typhimurium InfectionBruce McCollister, Cassandra V Kotter, Daniel N Frank, et al.
Mbio|November 1, 2012
A single native ganglioside GM1-binding site is sufficient for cholera toxin to bind to cells and complete the intoxication pathwayMichael G Jobling, Zhijie Yang, Wendy R Kam, et al.
Molecular Microbiology|July 9, 2002
LitR, a new transcriptional activator in Vibrio fischeri, regulates luminescence and symbiotic light organ colonizationPat M Fidopiastis, Carol M Miyamoto, Michael G Jobling, et al.
Biochemistry|March 31, 2004
Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanismClaire J O'Neal, Edward I Amaya, Michael G Jobling, et al.
Biophysical Journal|December 5, 2016
Glycolipid Crosslinking Is Required for Cholera Toxin to Partition Into and Stabilize Ordered DomainsKrishnan Raghunathan, Tiffany H Wong, Daniel J Chinnapen, et al.
Advances in Experimental Medicine and Biology|October 14, 2006
Dissection of the fusion machine of SARS-coronavirusMegan W Howard, Brian Tripet, Michael G Jobling, et al.
Biochemistry|September 16, 2010
Contribution of subdomain structure to the thermal stability of the cholera toxin A1 subunitTuhina Banerjee, Abhay Pande, Michael G Jobling, et al.
Plos One|July 2, 2011
Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable markerSheryl L W Zajdowicz, Jessica Jones-Carson, Andres Vazquez-Torres, et al.
Infection and Immunity|November 24, 2004
Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilisXin Li, Jarrod L Erbe, C Virginia Lockatell, et al.
Pageof 4